(Q40708465)

22 September 2017

title

Body mass index as a predictor of hepatic steatosis in living liver donors (English)

1 reference

22 September 2017

1 reference

4

Whitington P

1 reference

22 September 2017

Rinella ME

1

1 reference

22 September 2017

Alonso E

2

1 reference

22 September 2017

Rao S

3

1 reference

22 September 2017

Fryer J

5

1 reference

22 September 2017

Abecassis M

6

1 reference

22 September 2017

Superina R

7

1 reference

22 September 2017

Flamm SL

8

1 reference

22 September 2017

Blei AT

9

1 reference

22 September 2017

publication date

1 May 2001

1 reference

22 September 2017

published in

Liver Transplantation

1 reference

22 September 2017

volume

7

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

409-414

1 reference

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Raised liver enzymes in asymptomatic patients: investigation and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Use of fatty donor liver is associated with diminished early patient and graft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Safety of donors in live donor liver transplantation using right lobe grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Body fat topography as an independent predictor of fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Primary nonfunction of hepatic allografts with preexisting fatty infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Hepatic steatosis as a potential risk factor for major hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Hepatic steatosis in liver transplant donors: common feature of donor population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Hepatic effects of dietary weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2001.23787

21 January 2018

Identifiers

DOI

10.1053/JLTS.2001.23787

1 reference

22 September 2017

1 reference